IFNG and infection: Recent studies have demonstrated that the balance between Th17-mediated protection and pathology is crucial for defining the outcome of infections at the mucosa with IL-17 attracting IFN-γ-producing CD4+ Th1 cells to the lungs to control the infection19,20.